The present invention provides substituted pyrazine derivatives of Formula I, ##STR1##

that are CRF1 receptor antagonists, including human CRF1 receptors. This invention also relates to use of compounds of the invention for treating a disorder or condition, the treatment of which can be effected or facilitated by antagonizing a CRF receptor, such as CNS disorders, particularly anxiety-related disorders and mood disorders.

 
Web www.patentalert.com

< Molecular antigen array

< Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles

> Method for the treatment or prevention of viral infection using nucleoside analogues

> Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
~ 00220